Jie Wen

Dr. Jie Wen

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2025 in World Journal of Stem Cells
Verified
Journal Article
Open access
YYYang-Fei Yi
Yang-Fei Yi
ZFZi-Qi Fan
Zi-Qi Fan
CLCan Liu
Can Liu
YDYi-Tong Ding
Yi-Tong Ding
YCYao Chen
Yao Chen
YLYu-Fei Li
Yu-Fei Li
Exosomes (Exos) are extracellular vesicles secreted by cells and serve as crucial mediators of intercellular communication. They play a pivotal role in the pathogenesis and progression of various diseases and offer promising avenues for therapeutic interventions. Exos derived from mesenchymal stem cells (MSCs) have significant immunomodulatory properties. They effectively regulate immune responses by modulating both innate and adaptive immunity. These Exos can inhibit excessive inflammatory responses and promote tissue repair. Moreover, they participate in antigen presentation, which is essential for activating immune responses. The cargo of these Exos, including ligands, proteins, and microRNAs, can suppress T cell activity or enhance the population of immunosuppressive cells to dampen the immune response. By inhibiting lymphocyte proliferation, acting on macrophages, and increasing the population of regulatory T cells, these Exos contribute to maintaining immune and metabolic homeostasis. Furthermore, they can activate immune-related signaling pathways or serve as vehicles to deliver microRNAs and other bioactive substances to target tumor cells, which holds potential for immunotherapy applications. Given the immense therapeutic potential of MSC-derived Exos, this review comprehensively explores their mechanisms of immune regulation and therapeutic applications in areas such as infection control, tumor suppression, and autoimmune disease management. This article aims to provide valuable insights into the mechanisms behind the actions of MSC-derived Exos, offering theoretical references for their future clinical utilization as cell-free drug preparations.

24 September 2023 in World Journal of Clinical Oncology
Verified
Journal Article
Open access
JWJiang Wang
Jiang Wang
LLLan-Zhu Luo
Lan-Zhu Luo
DLDao-Miao Liang
Dao-Miao Liang
CGChao Guo
Chao Guo
ZHZhi-Hong Huang
Zhi-Hong Huang
JWJie Wen
Jie Wen
Developing novel cancer therapies that exploit programmed cell death pathways holds promise for advancing cancer treatment. According to a recently published study in Science, copper death (cuproptosis) occurs when intracellular copper is overloaded, triggering aggregation of lipidated mitochondrial proteins and Fe–S cluster proteins. This intriguing phenomenon is triggered by the instability of copper ions. Understanding the molecular mechanisms behind cuproptosis and its associated genes, as identified by Tsvetkov, including ferredoxin 1, lipoic acid synthase, lipoyltransferase 1, dihydrolipid amide dehydrogenase, dihydrolipoamide transacetylase, pyruvate dehydrogenase α1, pyruvate dehydrogenase β, metallothionein, glutaminase, and cyclin-dependent kinase inhibitor 2A, may open new avenues for cancer therapy. Here, we provide a new understanding of the role of copper death and related genes in cancer.

18 February 2023 in World Journal of Orthopedics
Verified
Journal Article
Open access
MZMing Zeng
Ming Zeng
ZXZheng Xu
Zheng Xu
ZSZhen-Qi Song
Zhen-Qi Song
JLJie-Xiao Li
Jie-Xiao Li
ZTZhong-Wen Tang
Zhong-Wen Tang
JWJie Wen
Jie Wen
Diagnosis and treatment of chronic osteomyelitis based on nanomaterials

18 June 2023 in World Journal of Orthopedics
Verified
Journal Article
Open access
DHDan Huang
Dan Huang
Djandan Tadum Arthur VithranDjandan Tadum Arthur Vithran
Djandan Tadum Arthur Vithran
HGHao-Li Gong
Hao-Li Gong
MZMing Zeng
Ming Zeng
ZTZhong-Wen Tang
Zhong-Wen Tang
SXSheng Xiao
Sheng Xiao
Effectiveness of platelet-rich plasma in the treatment of Achilles tendon disease

24 September 2023 in World Journal of Clinical Oncology
Verified
Journal Article
Open access
ZRZhou-Zhou Rao
Zhou-Zhou Rao
ZTZhong-Wen Tang
Zhong-Wen Tang
JWJie Wen
Jie Wen
Developing novel cancer therapies that exploit programmed cell death pathways holds promise for advancing cancer treatment. According to a recently published study in Science, copper death (cuproptosis) occurs when intracellular copper is overloaded, triggering aggregation of lipidated mitochondrial proteins and Fe–S cluster proteins. This intriguing phenomenon is triggered by the instability of copper ions. Understanding the molecular mechanisms behind cuproptosis and its associated genes, as identified by Tsvetkov, including ferredoxin 1, lipoic acid synthase, lipoyltransferase 1, dihydrolipid amide dehydrogenase, dihydrolipoamide transacetylase, pyruvate dehydrogenase α1, pyruvate dehydrogenase β, metallothionein, glutaminase, and cyclin-dependent kinase inhibitor 2A, may open new avenues for cancer therapy. Here, we provide a new understanding of the role of copper death and related genes in cancer.

16 December 2023 in World Journal of Clinical Cases
Verified
Journal Article
Open access
FXFeng Xiang
Feng Xiang
ZLZhi-Qing Liu
Zhi-Qing Liu
XZXi-Ping Zhang
Xi-Ping Zhang
YLYan-Jun Li
Yan-Jun Li
JWJie Wen
Jie Wen
Accessory navicular (AN) is a developmental variation of the secondary ossification center of the navicular tuberosity. Ten percent of patients with AN will have pain symptoms that affect walking and life. As the AN changes the position of the posterior tibial tendon insertion, children with AN often have posterior tibial tendon function insufficiency and flexible flat foot. Surgical treatment is often required after failure of conservative treatment. This article reviewed the etiology, clinical manifestations, complications, and treatment methods of AN.